INNO — Innocan Pharma Cashflow Statement
0.000.00%
Last trade - 00:00- CA$74.51m
- CA$69.60m
- $13.66m
- 52
- 15
- 31
- 24
Annual cashflow statement for Innocan Pharma, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -3.33 | -9.95 | -10.1 | -3.89 | -4.25 |
| Depreciation | |||||
| Non-Cash Items | 0.467 | 5.75 | 4.39 | -1.68 | 1.1 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.13 | 0.474 | -0.969 | -0.531 | -0.793 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Cash from Operating Activities | -2.71 | -3.69 | -6.63 | -6.07 | -3.9 |
| Capital Expenditures | -0.009 | 0 | -0.041 | -0.026 | -0.046 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | — | -0.007 | -0.005 | -0.038 |
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.009 | 0 | -0.048 | -0.031 | -0.084 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 4.45 | 4.02 | 15.3 | 0.125 | 2.92 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 1.76 | 0.365 | 8.71 | -6.1 | -1.06 |